JP2005501010A5 - - Google Patents

Download PDF

Info

Publication number
JP2005501010A5
JP2005501010A5 JP2003503004A JP2003503004A JP2005501010A5 JP 2005501010 A5 JP2005501010 A5 JP 2005501010A5 JP 2003503004 A JP2003503004 A JP 2003503004A JP 2003503004 A JP2003503004 A JP 2003503004A JP 2005501010 A5 JP2005501010 A5 JP 2005501010A5
Authority
JP
Japan
Prior art keywords
conjugate
pept2
transporter
vmax
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003503004A
Other languages
English (en)
Japanese (ja)
Other versions
JP4342934B2 (ja
JP2005501010A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/018686 external-priority patent/WO2002100172A1/en
Publication of JP2005501010A publication Critical patent/JP2005501010A/ja
Publication of JP2005501010A5 publication Critical patent/JP2005501010A5/ja
Application granted granted Critical
Publication of JP4342934B2 publication Critical patent/JP4342934B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003503004A 2001-06-11 2002-06-11 Ｐｅｐｔ−２輸送体を介した薬剤の投与 Expired - Fee Related JP4342934B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29773201P 2001-06-11 2001-06-11
US36100202P 2002-03-01 2002-03-01
PCT/US2002/018686 WO2002100172A1 (en) 2001-06-11 2002-06-11 Administration of agents via the pept-2 transporter

Publications (3)

Publication Number Publication Date
JP2005501010A JP2005501010A (ja) 2005-01-13
JP2005501010A5 true JP2005501010A5 (https=) 2006-01-05
JP4342934B2 JP4342934B2 (ja) 2009-10-14

Family

ID=26970290

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003503004A Expired - Fee Related JP4342934B2 (ja) 2001-06-11 2002-06-11 Ｐｅｐｔ−２輸送体を介した薬剤の投与

Country Status (4)

Country Link
US (3) US6955888B2 (https=)
EP (1) EP1406493A4 (https=)
JP (1) JP4342934B2 (https=)
WO (1) WO2002100172A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1406493A4 (en) * 2001-06-11 2006-06-14 Xenoport Inc ADMINISTRATION OF MEDIUM BY THE PEPT-2 TRANSPORTER
US20030158089A1 (en) * 2002-01-24 2003-08-21 Xenoport, Inc. Administrative agents via the SMVT transporter
US20050148534A1 (en) * 2003-09-22 2005-07-07 Castellino Angelo J. Small molecule compositions and methods for increasing drug efficiency using compositions thereof
US20100173864A1 (en) 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
US20110008327A1 (en) 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
US20100009928A1 (en) * 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
US20100028339A1 (en) 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
MXPA06011219A (es) 2004-03-29 2007-05-08 Univ South Florida Tratamiento efectivo de tumores y cancer con triciribina y compuestos relacionados.
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
TWI351284B (en) * 2004-04-09 2011-11-01 Chugai Pharmaceutical Co Ltd Novel water-soluble prodrugs
WO2006001986A2 (en) * 2004-06-04 2006-01-05 Xenoport, Inc. Glut3 transporters expressed in cancer cells
TW200744603A (en) 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
CN1870631B (zh) * 2005-11-11 2010-04-14 华为技术有限公司 媒体网关的门控方法
WO2008052044A2 (en) * 2006-10-26 2008-05-02 Xenoport, Inc. Use of derivatives of propofol for treating diseases associated with oxidative stress
US20090076141A1 (en) * 2007-09-14 2009-03-19 Xenoport, Inc. Use of Propofol Prodrugs for Treating Neuropathic Pain
US20090118365A1 (en) * 2007-11-06 2009-05-07 Xenoport, Inc Use of Prodrugs of GABA B Agonists for Treating Neuropathic and Musculoskeletal Pain
SG157299A1 (en) 2008-05-09 2009-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
EP4056686A1 (en) 2012-09-11 2022-09-14 Corning Incorporated Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
US20160178663A1 (en) * 2014-12-23 2016-06-23 Intel Corporation Formed wire probe interconnect for test die contactor

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504010B1 (fr) * 1981-04-15 1985-10-25 Sanofi Sa Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US4542225A (en) * 1984-08-29 1985-09-17 Dana-Farber Cancer Institute, Inc. Acid-cleavable compound
US4590071A (en) * 1984-09-25 1986-05-20 Xoma Corporation Human melanoma specific immunotoxins
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
ATE66469T1 (de) 1985-01-14 1991-09-15 Neorx Corp Metall-radionuklid markiertes protein fuer diagnose und therapie.
US4680338A (en) * 1985-10-17 1987-07-14 Immunomedics, Inc. Bifunctional linker
US4699784A (en) * 1986-02-25 1987-10-13 Center For Molecular Medicine & Immunology Tumoricidal methotrexate-antibody conjugate
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
AU668347B2 (en) 1990-11-21 1996-05-02 Torrey Pines Institute For Molecular Studies Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
IE920040A1 (en) * 1991-01-09 1992-07-15 Alza Corp Bioerodible devices and compositions for diffusional release¹of agents
US5770358A (en) 1991-09-18 1998-06-23 Affymax Technologies N.V. Tagged synthetic oligomer libraries
KR100310939B1 (ko) 1992-10-01 2002-06-20 추후제출 태그로암호화한복합조합화학라이브러리
IL108499A (en) * 1993-02-04 2000-02-29 Lilly Co Eli Mammalian influx peptide transporter
US5543158A (en) * 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US5565215A (en) * 1993-07-23 1996-10-15 Massachusettes Institute Of Technology Biodegradable injectable particles for imaging
BR9407947A (pt) 1993-11-02 1996-11-26 Affymax Tech Nv Processo para sintetizar moléculas diversas em uma pluralidade de substratos e uma coleçao molecular etiquetade para realizaçao reaçoes de copulaçao em contas em paralelo para triar uma coleçao molecular etiquetada para detectar a presença de um ou mais diferentes etiquetas e para determinar a sequência de síntese aparelho para reaçoes de copulaçao paralelas em suportes sólidos bloco de alinhamento ótico para uso com um detector ótico sistemas de distribuiçao para distribuir reagentes dispositiv
CA2189634A1 (en) 1994-05-06 1995-11-16 John J. Baldwin Combinatorial dihydrobenzopyran library
AU2553195A (en) 1994-05-23 1995-12-18 Arqule, Inc. Systematic modular production of aminimide- and oxazolone- based molecules having at least two structural diversity elements
US5663046A (en) 1994-06-22 1997-09-02 Pharmacopeia, Inc. Synthesis of combinatorial libraries
US5525735A (en) 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
US7413536B1 (en) 1999-09-14 2008-08-19 Xenoport, Inc. Substrates and screening methods for transport proteins
AU2002345638A1 (en) * 2001-06-11 2002-12-23 Xenoport, Inc. Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
EP1406493A4 (en) * 2001-06-11 2006-06-14 Xenoport Inc ADMINISTRATION OF MEDIUM BY THE PEPT-2 TRANSPORTER

Similar Documents

Publication Publication Date Title
JP2005501010A5 (https=)
FI120817B (fi) Intrabukkaalisesti liukenevat puristustuotteet ja näiden valmistusmenetelmä
Ghosh et al. A review on new generation orodispersible tablets and its future prospective
EP1267941B1 (en) Alprazolam inclusion complexes and pharmaceutical compositions thereof
US20090202635A1 (en) Delivery System, Application, and Method
JP4435424B2 (ja) 口腔内で速やかに崩壊する錠剤
US20040208931A1 (en) Fast dissolving films for oral administration of drugs
JP2005529847A5 (https=)
JP2643426B2 (ja) 非経口投与用薬剤組成物
US20140275509A1 (en) Multifunctionalized materials
WO2003094886A3 (en) Desmopressin in an orodispersible dosage form
ATE233752T1 (de) Liponsaürederivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
PT934058E (pt) Forma estavel de medicamento para a administracao por via oral com derivados de benzimidazole como substancia activa e processo para a sua producao
CN104208715A (zh) 具有提高的药物生物活性的低分子量聚乙二醇药物结合物
JP2010520174A5 (https=)
ATE522513T1 (de) N-phenylarylsulfonamidverbindung, arzneimittel das diese verbindung als wirkstoff enthält, zwischenprodukt für die verbindung und verfahren zu dessen herstellung
NZ580967A (en) Composition comprising a bile salt and an effervescent excipient component for transmucosal delivery of polypeptides
WO2003103713A1 (ja) 速崩壊性錠剤及びその製造方法
ITMI960358A1 (it) Citochine modificate per l'uso in terapia
CA2310028A1 (en) High drug load immediate and modified release oral dosage formulations and processes for their manufacture
CN106924289A (zh) 一种含硝唑类抗菌药的复方口腔用药及其制备方法
Schechter et al. Organ selective delivery using a tissue-directed sreptavidin-biotin system: targeting 5-fluorouridine via TNP-streptavidin
JPS6115829A (ja) 口腔粘膜適用徐放性ニフエジピン製剤
JP2023549126A5 (https=)
JP2005522454A5 (https=)